BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 32497020)

  • 41. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.
    Wu G; Zhou H; Li D; Zhi Y; Liu Y; Li J; Wang F
    Exp Cell Res; 2020 Nov; 396(2):112331. PubMed ID: 33058834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer.
    Xu ST; Xu JH; Zheng ZR; Zhao QQ; Zeng XS; Cheng SX; Liang YH; Hu QF
    Biomed Pharmacother; 2017 Dec; 96():14-21. PubMed ID: 28961506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.
    Wang X; Chen T; Li C; Li W; Zhou X; Li Y; Luo D; Zhang N; Chen B; Wang L; Zhao W; Fu S; Yang Q
    J Hematol Oncol; 2022 Aug; 15(1):122. PubMed ID: 36038948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.
    Zhang L; Song X; Chen X; Wang Q; Zheng X; Wu C; Jiang J
    Int J Biol Sci; 2019; 15(5):1091-1103. PubMed ID: 31182928
    [No Abstract]   [Full Text] [Related]  

  • 45. Circ-TRIO promotes TNBC progression by regulating the miR-432-5p/CCDC58 axis.
    Wang Z; Li Y; Yang J; Liang Y; Wang X; Zhang N; Kong X; Chen B; Wang L; Zhao W; Yang Q
    Cell Death Dis; 2022 Sep; 13(9):776. PubMed ID: 36075896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
    Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
    J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
    Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
    Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression.
    Chen B; Wei W; Huang X; Xie X; Kong Y; Dai D; Yang L; Wang J; Tang H; Xie X
    Theranostics; 2018; 8(14):4003-4015. PubMed ID: 30083277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FUS-induced circular RNA ZNF609 promotes tumorigenesis and progression via sponging miR-142-3p in lung cancer.
    Liu S; Yang N; Jiang X; Wang J; Dong J; Gao Y
    J Cell Physiol; 2021 Jan; 236(1):79-92. PubMed ID: 33459380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer.
    Wang X; Xue B; Zhang Y; Guo G; Duan X; Dou D
    Cell Death Dis; 2021 Apr; 12(5):412. PubMed ID: 33875646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
    Zhao M; Zhang M; Tao Z; Cao J; Wang L; Hu X
    Technol Cancer Res Treat; 2020; 19():1533033820905824. PubMed ID: 32174262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.
    Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X
    Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8.
    Zeng X; Ma X; Guo H; Wei L; Zhang Y; Sun C; Han N; Sun S; Zhang N
    Bioengineered; 2021 Dec; 12(2):10126-10135. PubMed ID: 34978519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression.
    Yang X; Yang Y; Qian X; Xu X; Lv P
    Biomed J; 2022 Jun; 45(3):512-521. PubMed ID: 35715331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression.
    Wu Y; Xie Z; Chen J; Chen J; Ni W; Ma Y; Huang K; Wang G; Wang J; Ma J; Shen S; Fan S
    Mol Cancer; 2019 Apr; 18(1):73. PubMed ID: 30940151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dual Suppressive Effect of miR-34a on the FOXM1/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion.
    Bayraktar R; Ivan C; Bayraktar E; Kanlikilicer P; Kabil NN; Kahraman N; Mokhlis HA; Karakas D; Rodriguez-Aguayo C; Arslan A; Sheng J; Wong S; Lopez-Berestein G; Calin GA; Ozpolat B
    Clin Cancer Res; 2018 Sep; 24(17):4225-4241. PubMed ID: 29748184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.